Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Attention Deficit Disorder with Hyperactivity

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Attention Deficit Disorder with Hyperactivity in 2 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alves, CB1
Almeida, AS1
Marques, DM1
Faé, AHL1
Machado, ACL1
Oliveira, DL1
Portela, LVC1
Porciúncula, LO1
Pires, VA1
Pamplona, FA1
Pandolfo, P1
Fernandes, D1
Prediger, RD1
Takahashi, RN1

Other Studies

2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Attention Deficit Disorder with Hyperactivity

ArticleYear
Caffeine and adenosine A
    Neuropharmacology, 2020, Volume: 166

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Animals; Attention Deficit Disord

2020
Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder.
    Behavioural pharmacology, 2009, Volume: 20, Issue:2

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Attention Deficit Dis

2009